![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
IMO-2125, a TLR9 Agonist, Induces Immune ResponsesWhich Correlate With Reductions In Viral Load In Null Responder HCV Patients
|
|
|
Reported by Jules Levin
AASLD Nov 1 2010 Boston
M Rodriguez-Torres, RH Ghalib, SC Gordon, E Lawitz,K Patel, R Pruitt, AM Sheikh, RD Arbeit, AS Bexon, ER Kandimalla, M Precopio, T Sullivan, AJ Muir, JG McHutchison
![](../images/110610/110610-1/image002.gif)
![](../images/110610/110610-1/image004.gif)
![](../images/110610/110610-1/image006.gif)
![](../images/110610/110610-1/image008.gif)
![](../images/110610/110610-1/image010.gif)
![](../images/110610/110610-1/image012.gif)
![](../images/110610/110610-1/image014.gif)
![](../images/110610/110610-1/image016.gif)
![](../images/110610/110610-1/image018.gif)
![](../images/110610/110610-1/image020.gif)
![](../images/110610/110610-1/image022.gif)
![](../images/110610/110610-1/image024.gif)
![](../images/110610/110610-1/image026.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|